- Home
- BOLT vs SYNX Comparison
BOLT vs SYNX Comparison
Compare BOLT & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- SYNX
- Stock Information
- Founded
- BOLT 2015
- SYNX 2005
- Country
- BOLT United States
- SYNX Israel
- Employees
- BOLT N/A
- SYNX N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- SYNX
- Sector
- BOLT Health Care
- SYNX
- Exchange
- BOLT Nasdaq
- SYNX Nasdaq
- Market Cap
- BOLT 10.4M
- SYNX 10.2M
- IPO Year
- BOLT 2021
- SYNX 2024
- Fundamental
- Price
- BOLT $5.75
- SYNX $1.66
- Analyst Decision
- BOLT Buy
- SYNX
- Analyst Count
- BOLT 3
- SYNX 0
- Target Price
- BOLT $47.50
- SYNX N/A
- AVG Volume (30 Days)
- BOLT 39.8K
- SYNX 82.7K
- Earning Date
- BOLT 11-11-2025
- SYNX 09-26-2025
- Dividend Yield
- BOLT N/A
- SYNX N/A
- EPS Growth
- BOLT N/A
- SYNX N/A
- EPS
- BOLT N/A
- SYNX N/A
- Revenue
- BOLT $4,167,000.00
- SYNX $6,003,000.00
- Revenue This Year
- BOLT N/A
- SYNX $32.35
- Revenue Next Year
- BOLT N/A
- SYNX N/A
- P/E Ratio
- BOLT N/A
- SYNX N/A
- Revenue Growth
- BOLT N/A
- SYNX N/A
- 52 Week Low
- BOLT $4.59
- SYNX $1.37
- 52 Week High
- BOLT $14.36
- SYNX $6.49
- Technical
- Relative Strength Index (RSI)
- BOLT 52.63
- SYNX 51.92
- Support Level
- BOLT $5.62
- SYNX $1.61
- Resistance Level
- BOLT $6.38
- SYNX $1.82
- Average True Range (ATR)
- BOLT 0.43
- SYNX 0.09
- MACD
- BOLT 0.01
- SYNX 0.02
- Stochastic Oscillator
- BOLT 41.53
- SYNX 64.21
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.